[Form 4] Guardant Health, Inc. Insider Trading Activity
Darya Chudova, identified as Chief Technology Officer of Guardant Health, Inc. (GH), reported changes in beneficial ownership on a Form 4 filed for transactions dated 09/01/2025. The filing shows 316 restricted stock units deemed acquired at $0 (coded M) related to RSU vesting, and a reported disposition of 161 shares at $67.42. Following the transactions, the reporting person is shown as beneficially owning 81,610 shares after the acquisition line and 81,449 after the disposition line. The RSU award was originally granted on November 2, 2021 and fully vests on September 1, 2025, with vesting occurring in equal quarterly installments.
Darya Chudova, indicata come Chief Technology Officer di Guardant Health, Inc. (GH), ha segnalato variazioni nella propriet脿 beneficiaria con un Form 4 relativo a operazioni datate 01/09/2025. La dichiarazione riporta l'acquisizione di 316 restricted stock unit considerate acquisite a $0 (codice M) per effetto del vesting delle RSU e una cessione di 161 azioni a $67.42. Dopo le operazioni, la persona che segnala risulta beneficiariamente titolare di 81.610 azioni dopo l'acquisizione e di 81.449 dopo la disposizione. L'assegnazione delle RSU 猫 stata originariamente concessa il 2 novembre 2021 e si completa in vesting il 1 settembre 2025, con maturazione in quote trimestrali uguali.
Darya Chudova, identificada como Chief Technology Officer de Guardant Health, Inc. (GH), notific贸 cambios en la propiedad beneficiaria mediante un Form 4 por operaciones fechadas el 01/09/2025. El informe muestra la adquisici贸n de 316 unidades restringidas (RSU) consideradas adquiridas a $0 (c贸digo M) por el vesting, y una disposici贸n reportada de 161 acciones a $67.42. Tras las operaciones, la persona informante aparece con 81.610 acciones en propiedad beneficiaria luego de la adquisici贸n y con 81.449 tras la disposici贸n. La concesi贸n de RSU se otorg贸 originalmente el 2 de noviembre de 2021 y vence completamente el 1 de septiembre de 2025, con vesting en cuotas trimestrales iguales.
雼る灤 於旊弰氚�(Darya Chudova)電� Guardant Health, Inc.(GH)鞚� 斓滉碃旮办垹毂呾瀯鞛�(CTO)搿� 頇曥澑霅橂┌, 2025-09-01鞛� 瓯半灅鞐� 甏�頃� 靻岇湢甓� 氤�霃欖潉 Form 4搿� 氤搓碃頄堨姷雼堧嫟. 頃措嫻 鞁犼碃靹滌棎電� RSU(鞝滍暅欤检嫕雼渼) 氩犾姢韺呾棎 霐半澕 $0(旖旊摐 M)搿� 臧勳＜ 旆摑霅� 316 雼渼鞕赌, $67.42鞐� 氤搓碃霅� 161欤检潣 觳橂秳鞚� 旮办灛霅橃柎 鞛堨姷雼堧嫟. 瓯半灅 頉� 氤搓碃鞚胳潃 旆摑 頉� 旮办鞙茧 81,610欤�, 觳橂秳 頉� 旮办鞙茧 81,449欤检潣 鞁れ唽鞙犼秾鞚� 氤挫湢頃� 瓴冹溂搿� 雮橅儉雮╇媹雼�. 頃措嫻 RSU電� 鞗愲灅 2021雲� 11鞗� 2鞚�鞐� 攵�鞐悩鞐堦碃, 2025雲� 9鞗� 1鞚�鞐� 鞝勲秬 氩犾姢韺呺悩氅� 攵勴暊鞚� 霃欖澕頃� 攵勱赴氤� 頃犽秬搿� 鞚措（鞏挫雼堧嫟.
Darya Chudova, identifi茅e comme Chief Technology Officer de Guardant Health, Inc. (GH), a d茅clar茅 des changements de propri茅t茅 b茅n茅ficiaire dans un Form 4 pour des op茅rations dat茅es du 01/09/2025. Le d茅p么t indique l'acquisition de 316 unit茅s d'actions restreintes (RSU) r茅put茅es acquises 脿 $0 (code M) suite au vesting, et une cession d茅clar茅e de 161 actions 脿 $67.42. Apr猫s ces op茅rations, la personne d茅clarante d茅tient 81 610 actions apr猫s la ligne d'acquisition et 81 449 apr猫s la ligne de disposition. L'attribution des RSU a 茅t茅 initialement accord茅e le 2 novembre 2021 et vestera int茅gralement le 1er septembre 2025, par versements trimestriels 茅gaux.
Darya Chudova, ausgewiesen als Chief Technology Officer von Guardant Health, Inc. (GH), meldete 脛nderungen des wirtschaftlichen Eigentums in einem Form 4 f眉r Transaktionen vom 01.09.2025. Die Meldung f眉hrt 316 Restricted Stock Units auf, die im Zuge des RSU-Vestings zu $0 (Code M) als erworben gelten, sowie eine gemeldete Ver盲u脽erung von 161 Aktien zu $67.42. Nach den Transaktionen wird die meldende Person mit 81.610 Aktien nach der Erwerbslinie und mit 81.449 Aktien nach der Ver盲u脽erungslinie als wirtschaftlich berechtigt ausgewiesen. Die RSU-Zuteilung wurde urspr眉nglich am 2. November 2021 gew盲hrt und vestet vollst盲ndig am 1. September 2025, jeweils in gleichen viertelj盲hrlichen Raten.
- RSUs vested: 316 restricted stock units recorded as acquired at $0, reflecting compensation realization
- Clear vesting schedule: RSU grant dated Nov 2, 2021 with full vesting on Sep 1, 2025, disclosed in the filing
- Compliance: Form 4 filed and signed by attorney-in-fact, meeting reporting requirements
- Disposition reported: 161 shares disposed at $67.42, reducing beneficial ownership from 81,610 to 81,449 shares
Insights
TL;DR: Routine executive equity vesting with a small reported disposition; not a material capital markets event.
The Form 4 documents standard equity compensation activity for an executive: 316 RSUs vesting (recorded as acquisition at $0) and a contemporaneous reported disposition of 161 shares at $67.42. Post-transaction beneficial ownership is shown around ~81.4k shares. This appears to reflect scheduled vesting and a minor sale or withholding, rather than a large open-market trade or change in control.
TL;DR: Disclosure meets Section 16 reporting requirements for officer equity activity; vesting schedule is documented.
The filing identifies the reporting person as an officer (Chief Technology Officer) and provides the RSU grant history and vesting schedule (grant dated Nov 2, 2021, fully vesting Sep 1, 2025). The form is signed by an attorney-in-fact, indicating procedural compliance. The entries are specific and tied to the documented grant and vesting timeline.
Darya Chudova, indicata come Chief Technology Officer di Guardant Health, Inc. (GH), ha segnalato variazioni nella propriet脿 beneficiaria con un Form 4 relativo a operazioni datate 01/09/2025. La dichiarazione riporta l'acquisizione di 316 restricted stock unit considerate acquisite a $0 (codice M) per effetto del vesting delle RSU e una cessione di 161 azioni a $67.42. Dopo le operazioni, la persona che segnala risulta beneficiariamente titolare di 81.610 azioni dopo l'acquisizione e di 81.449 dopo la disposizione. L'assegnazione delle RSU 猫 stata originariamente concessa il 2 novembre 2021 e si completa in vesting il 1 settembre 2025, con maturazione in quote trimestrali uguali.
Darya Chudova, identificada como Chief Technology Officer de Guardant Health, Inc. (GH), notific贸 cambios en la propiedad beneficiaria mediante un Form 4 por operaciones fechadas el 01/09/2025. El informe muestra la adquisici贸n de 316 unidades restringidas (RSU) consideradas adquiridas a $0 (c贸digo M) por el vesting, y una disposici贸n reportada de 161 acciones a $67.42. Tras las operaciones, la persona informante aparece con 81.610 acciones en propiedad beneficiaria luego de la adquisici贸n y con 81.449 tras la disposici贸n. La concesi贸n de RSU se otorg贸 originalmente el 2 de noviembre de 2021 y vence completamente el 1 de septiembre de 2025, con vesting en cuotas trimestrales iguales.
雼る灤 於旊弰氚�(Darya Chudova)電� Guardant Health, Inc.(GH)鞚� 斓滉碃旮办垹毂呾瀯鞛�(CTO)搿� 頇曥澑霅橂┌, 2025-09-01鞛� 瓯半灅鞐� 甏�頃� 靻岇湢甓� 氤�霃欖潉 Form 4搿� 氤搓碃頄堨姷雼堧嫟. 頃措嫻 鞁犼碃靹滌棎電� RSU(鞝滍暅欤检嫕雼渼) 氩犾姢韺呾棎 霐半澕 $0(旖旊摐 M)搿� 臧勳＜ 旆摑霅� 316 雼渼鞕赌, $67.42鞐� 氤搓碃霅� 161欤检潣 觳橂秳鞚� 旮办灛霅橃柎 鞛堨姷雼堧嫟. 瓯半灅 頉� 氤搓碃鞚胳潃 旆摑 頉� 旮办鞙茧 81,610欤�, 觳橂秳 頉� 旮办鞙茧 81,449欤检潣 鞁れ唽鞙犼秾鞚� 氤挫湢頃� 瓴冹溂搿� 雮橅儉雮╇媹雼�. 頃措嫻 RSU電� 鞗愲灅 2021雲� 11鞗� 2鞚�鞐� 攵�鞐悩鞐堦碃, 2025雲� 9鞗� 1鞚�鞐� 鞝勲秬 氩犾姢韺呺悩氅� 攵勴暊鞚� 霃欖澕頃� 攵勱赴氤� 頃犽秬搿� 鞚措（鞏挫雼堧嫟.
Darya Chudova, identifi茅e comme Chief Technology Officer de Guardant Health, Inc. (GH), a d茅clar茅 des changements de propri茅t茅 b茅n茅ficiaire dans un Form 4 pour des op茅rations dat茅es du 01/09/2025. Le d茅p么t indique l'acquisition de 316 unit茅s d'actions restreintes (RSU) r茅put茅es acquises 脿 $0 (code M) suite au vesting, et une cession d茅clar茅e de 161 actions 脿 $67.42. Apr猫s ces op茅rations, la personne d茅clarante d茅tient 81 610 actions apr猫s la ligne d'acquisition et 81 449 apr猫s la ligne de disposition. L'attribution des RSU a 茅t茅 initialement accord茅e le 2 novembre 2021 et vestera int茅gralement le 1er septembre 2025, par versements trimestriels 茅gaux.
Darya Chudova, ausgewiesen als Chief Technology Officer von Guardant Health, Inc. (GH), meldete 脛nderungen des wirtschaftlichen Eigentums in einem Form 4 f眉r Transaktionen vom 01.09.2025. Die Meldung f眉hrt 316 Restricted Stock Units auf, die im Zuge des RSU-Vestings zu $0 (Code M) als erworben gelten, sowie eine gemeldete Ver盲u脽erung von 161 Aktien zu $67.42. Nach den Transaktionen wird die meldende Person mit 81.610 Aktien nach der Erwerbslinie und mit 81.449 Aktien nach der Ver盲u脽erungslinie als wirtschaftlich berechtigt ausgewiesen. Die RSU-Zuteilung wurde urspr眉nglich am 2. November 2021 gew盲hrt und vestet vollst盲ndig am 1. September 2025, jeweils in gleichen viertelj盲hrlichen Raten.
FAQ
What transactions did Darya Chudova report on the Form 4 for GH?
How many Guardant Health (GH) shares does the filing show Darya Chudova beneficially owns after the transactions?
When do the restricted stock units fully vest according to the Form 4?
What role does Darya Chudova hold at Guardant Health as indicated on the Form 4?
Who signed the Form 4 and when was it signed?
